News

18.12.2025

Defining the Best Patient Group for IMMUTOL’s New Cell Therapy: MS Patients Speak Out 

On 25 November 2025, European Multiple Sclerosis Platform (EMSP) organised a consultation between the Multiple Sclerosis Community Advisory Board (MSCAB),…